BRIGHTE: Wk 96 Results From Phase III Study of Fostemsavir + OBT in Heavily Treatment–Experienced Patients Failing Current ART

July 21-24, 2019; Mexico City, Mexico
Virologic suppression rates and CD4+ cell counts continued to improve through Week 96 in this difficult-to-treat population receiving fostemsavir plus optimized background therapy.
Format: Microsoft PowerPoint (.ppt)
File Size: 298 KB
Released: July 24, 2019

Acknowledgements

Provided by USF

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)
cpdsupport@usf.edu
https://health.usf.edu/cpd

Produced in collaboration with
IAS 2019 Media Partner Logo
Educational grant provided by:
Gilead Sciences
ViiV Healthcare

Related Content

Firsthand perspective from Melanie A. Reese, on understanding the psychosocial issues faced by patients living with and aging with HIV

Melanie Reese Released: January 4, 2021

Clinical Care Options (CCO) presenta las reflexiones de la Dra. Leticia M. Pérez Saleme sobre cómo ha cambiado la atención de pacientes con VIH durante la pandemia de COVID-19 en México.

Leticia M. Pérez Saleme, MD Released: December 31, 2020

Multimedia module from Clinical Care Options: HIV experts review new/emerging strategies for initial HIV treatment, switching ART, and HIV prevention

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Daniel R. Kuritzkes, MD Paul E. Sax, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: December 30, 2020 Expired: December 29, 2021

Download free expert-authored slides reviewing current issues related to HIV care including weight gain, ART simplification, and ART safety in pregnancy

José R. Arribas, MD Released: December 23, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue